METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to extend life in advanced esophageal cancer
Disease control CompletedThis study tests whether adding lenvatinib to pembrolizumab and chemotherapy helps people with metastatic esophageal cancer live longer. About 864 participants receive either the new three-drug combo or standard care. The goal is to improve overall survival, but this is not a cur…
Matched conditions: METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Real-World data reveals immunotherapy Combo's impact on esophageal cancer
Knowledge-focused CompletedThis study analyzed medical records from 1197 patients in China with advanced esophageal cancer who received immunotherapy (anti-PD-1) plus chemotherapy as their first treatment. The goal was to see how long patients lived and how long the cancer stayed under control in everyday …
Matched conditions: METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC